Nyxoah SA ROE 2021-2024 | NYXH
Current and historical return on equity (ROE) values for Nyxoah SA (NYXH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Nyxoah SA ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $-0.06B | $0.12B | -52.13% |
| 2024-06-30 | $-0.05B | $0.13B | -41.96% |
| 2024-03-31 | $-0.05B | $0.10B | -42.25% |
| 2023-12-31 | $-0.05B | $0.11B | -38.84% |
| 2023-09-30 | $-0.05B | $0.12B | -38.81% |
| 2023-06-30 | $-0.05B | $0.13B | -36.08% |
| 2023-03-31 | $-0.04B | $0.13B | -28.04% |
| 2022-12-31 | $-0.03B | $0.13B | -23.24% |
| 2022-03-31 | $-0.02B | $0.16B | -16.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||